Literature DB >> 21751623

Prognostic markers in AIDS-related cryptococcal meningitis.

S Majumder1, S K Mandal, D Bandyopadhyay.   

Abstract

OBJECTIVE: Despite the advent and expanding access to antiretroviral therapy, HIV-associated cryptococcal meningitis (CM) remains a significant cause of mortality and morbidity amongst individuals with this infection in resource-limited settings.
METHODS: We prospectively studied the clinical, biochemical and mycological parameters of 30 HIV patients diagnosed with cryptococcal meningitis at our centre over a period of 6 months with a view to identify prognostic factors predictive of poor outcome.
RESULTS: Our study documented a mortality rate of 36.7%. Age, sex and previous diagnosis of HIV had no bearing on the survival outcome of patients. The study identified several poor prognostic factors including low GCS score, papilledema, elevated CSF opening pressure (>250 mm of H2O) and lack of regular HIV care in those with a prior diagnosis of HIV. CSF pleocytosis was significantly higher in the mortality group.
CONCLUSION: There have been relatively few attempts to focus on poor prognostic markers associated with AIDS related Cryptococcal meningitis in Asian patients. Our study highlights how simple bedside clinical tools like ophthalmoscopy and CSF manometry can help in risk stratification in this group of patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21751623

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  7 in total

1.  [Early ventricle-atrium shunts for treating cryptococcal meningitis in children].

Authors:  Shi-Qi Guang; Fang He; Li-Wen Wu; Fei Yin; Jing Peng
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2018-10

2.  Prediction of unfavorable outcomes in cryptococcal meningitis: results of the multicenter Infectious Diseases International Research Initiative (ID-IRI) cryptococcal meningitis study.

Authors:  I N Hakyemez; H Erdem; G Beraud; M Lurdes; A Silva-Pinto; C Alexandru; B Bishop; F Mangani; X Argemi; M Poinot; R Hasbun; M Sunbul; M Akcaer; S Alp; T Demirdal; K Angamuthu; F Amer; E Ragab; G A Shehata; D Ozturk-Engin; N Ozgunes; L Larsen; S Zimmerli; O R Sipahi; E Tukenmez Tigen; G Celebi; N Oztoprak; A C Yardimci; Y Cag
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-12-08       Impact factor: 3.267

3.  A retrospective research of HIV-negative cryptococcal meningoencephalitis patients with acute/subacute onset.

Authors:  H Zheng; Q Chen; Z Xie; D Wang; M Li; X Zhang; Y Man; J Lao; N Chen; L Zhou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-20       Impact factor: 3.267

4.  Human immunodefeciency virus associated cryptococcal meningitis at a tertiary care centre: diagnostic tools and antifungal susceptibility testing.

Authors:  Rashmi Munivenkataswamy; Anjana Gopi; Shaik Mohammed Usman
Journal:  J Clin Diagn Res       Date:  2013-08-01

5.  Comparison of clinical features and prognostic factors in HIV-negative adults with cryptococcal meningitis and tuberculous meningitis: a retrospective study.

Authors:  Junyan Qu; Taoyou Zhou; Cejun Zhong; Rong Deng; Xiaoju Lü
Journal:  BMC Infect Dis       Date:  2017-01-10       Impact factor: 3.090

6.  Prevalence of cryptococcal meningitis among people living with human immuno-deficiency virus and predictors of mortality in adults on induction therapy in Africa: A systematic review and meta-analysis.

Authors:  Seke G Y Muzazu; Dawit Getachew Assefa; Christabel Phiri; Tewodros Getinet; Samrawit Solomon; Gizachew Yismaw; Tsegahun Manyazewal
Journal:  Front Med (Lausanne)       Date:  2022-09-08

7.  Blood neutrophil counts in HIV-infected patients with cryptococcal meningitis: Association with mortality.

Authors:  Abdu Kisekka Musubire; David B Meya; Joshua Rhein; Graeme Meintjes; Paul R Bohjanen; Edwin Nuwagira; Conrad Muzoora; David R Boulware; Kathy Huppler Hullsiek
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.